*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : UY0870000
CHEMICAL NAME : Pyrrolidine,
3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene
)-1-ethyl-2-methyl-, hydrochloride
CAS REGISTRY NUMBER : 16378-22-6
LAST UPDATED : 199204
DATA ITEMS CITED : 14
MOLECULAR FORMULA : C22-H25-N.Cl-H
MOLECULAR WEIGHT : 339.94
WISWESSER LINE NOTATION : L C676 BY&T&J BU- CT5N CYTJ A2 B1 &GH
COMPOUND DESCRIPTOR : Drug
SYNONYMS/TRADE NAMES :
* Piroheptine hydrochloride
* Trimol
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 600 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 4,467,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 4,467,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 330 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 22,961,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 16 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 4,467,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 127 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 22,961,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 78 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 22,961,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 91 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag,
Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
Volume(issue)/page/year: 22,961,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 19 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
IYKEDH Iyakuhin Kenkyu. Study of Medical Supplies. (Nippon Koteisho
Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan) V.1- 1970-
Volume(issue)/page/year: 4,467,1973
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 195 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 12500 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 383 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 6200 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 3250 mg/kg/30D-I
TOXIC EFFECTS :
Blood - changes in cell count (unspecified)
Nutritional and Gross Metabolic - weight loss or decreased weight gain
Biochemical - Enzyme inhibition, induction, or change in blood or tissue
levels - phosphatases
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Oral
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 19500 mg/kg/26W-I
TOXIC EFFECTS :
Cardiac - changes in heart weight
Liver - changes in liver weight
Nutritional and Gross Metabolic - weight loss or decreased weight gain
REFERENCE :
KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda
Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960-
Volume(issue)/page/year: 6,941,1972
*** END OF RECORD ***
|
|
|
| ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| | NAME | CAS |
|
1,2-Pyrrolidinedicarboxamide, N(sup1)-(2-chloroethyl)-N(sup 1)-nitroso-, (S)-
| 81965-44-8 |
|
1,2-Pyrrolidinedicarboxylic acid, 1-benzyl ester, L-
| 1148-11-4 |
|
1,2-Pyrrolidinedicarboxylic acid, 1-benzyl2-(1,2-dibromoethyl) ester
| 64187-33-3 |
|
1,2-Pyrrolidinedicarboxylic acid, 1-benzylp-nitrophenyl ester, L-
| 3304-59-4 |
|
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-
| 62613-82-5 |
|
1,2-Pyrrolidinedicarboxylic acid, 2-ethenyl1-(phenylmethyl) ester, (S)-
| 64187-32-2 |
|
2,2-Pyrrolidinedicarboxylic acid, 3-isopropyl-5-oxo-,diethyl ester
| 2445-91-2 |
|
Pyrrolidine,1-(2-(7,8-dichloro-11H-dibenzo(b,e)(1,4)dioxepin-11-yl)ethyl)-, hydrochloride, (+-)-
| 81320-49-2 |
|
Pyrrolidine, 3,4-dichloro-N-nitroso-
| 59863-59-1 |
|
Pyrrolidine, 2-((3,4-dichlorophenyl)imino)-1-propyl-
| 27050-40-4 |
|
Pyrrolidine, 2-(2,2-dicyclohexylethyl)-,hydrochloride
| 63722-64-5 |
|
Pyrrolidine,1-(4-(diethylamino)-2,2-diphenylbutyryl)-,monohydrochloride
| 63722-64-5 |
|
Pyrrolidine, 1-(6-(diethylamino)-2-hexynyl)-
| 6628-90-6 |
|
Pyrrolidine,1-(N,N-diethylglycyl)-2,2,5,5-tetramethyl-
| 53725-38-5 |
|
Pyrrolidine,1-(2-(4-(2,2-diethyl-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl )-, hydrochloride
| 57897-58-2 |
|
1-Pyrrolidineacetamide, 3-hydroxy-2-oxo-, (+-)-
| 85404-68-8 |
|
Pyrrolidine,1-(6,7-dihydro-5H-benzocyclohepten-7-yl)-,(E)-2-butenedioate (2:1)
| 62819-73-2 |
|
Pyrrolidine,3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methyl-, hydrochloride
| 16378-22-6 |
|
Pyrrolidine,3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidenemethyl)-1-methyl,
| 29128-69-6 |
|
Pyrrolidine,1-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)-3-(methylamino)-
| 69159-51-9 |
|
Pyrrolidine,1-(4-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)-2-butynyl)-, maleate
| 69159-51-9 |
|
Pyrrolidine,1-(2-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)ethyl)-, oxalate
| 15475-33-9 |
|
Pyrrolidine,3-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)-1-methyl-, maleate (1:1)
| 1057-59-6 |
|
Pyrrolidine,1-((3a,12b-dihydrodibenzo(b,f)-1,3-dioxolo(4,5-d)oxepin-2-yl)methyl)-
| 84646-78-6 |
|
Pyrrolidine,1-(2-(6,11-dihydrodibenz(b,e)oxepin-6-yl)ethyl)-,(+-)-, (E)-2-butenedioate (1:1)
| 86640-22-4 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-2,2-diethyl-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, hydrochloride
| 86640-22-4 |
|
1-Pyrrolidineacetamide, 3-hydroxy-2-oxo-, (R)-
| 85348-47-6 |
|
Pyrrolidine,1-((3,4-dihydro-6,7-dimethoxy-1H-2-benzopyran-1-yl)methyl)-, hydrochloride
| 70100-63-9 |
|
Pyrrolidine,1-(2,3-dihydro-2,2-dimethyl-3-benzofuranyl)-
| 58774-94-0 |
|
Pyrrolidine,1-((3,4-dihydro-3,3-dimethyl-1(2H)-isoquinolinylidene)acetyl)-, monohydrochloride, (Z)-
| 126356-29-4 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-2,2-dimethyl-7-methoxy-4-phenyl-2H-1-benzopyran-3-yl) phenoxy)ethyl)-, (E)-
| 84394-37-6 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-2,2-dimethyl-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, hydrochloride,(E)-
| 84394-37-6 |
|
Pyrrolidine,1-(3-(4-(3,4-dihydro-2,2-dimethyl-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)propyl)-,hydrochloride, (E)-
| 84394-09-2 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, cis-
| 51423-20-2 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, hydrochloride,trans-(-)-
| 79386-05-3 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, hydrochloride,trans-(+)-
| 92083-15-3 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl) phenoxy)ethyl)-, hydrochloride,trans-(+-)-
| 103150-29-4 |
|
1-Pyrrolidineacetamide, 3-hydroxy-2-oxo-, (S)-
| 85348-46-5 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl )-, (E)-
| 33382-08-0 |
|
Pyrrolidine,1-(2-(4-(3,4-dihydro-7-methoxy-3-phenyl-2H-1-benzopyran-4-yl)phenoxy)ethyl )-, (Z)-
| 33382-06-8 |
|
Pyrrolidine,1-(2-(p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)-
| 1845-11-0 |
|
Pyrrolidine,1-(2-(p-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)-, hydrochloride
| 1847-63-8 |
|
Pyrrolidine,1-((1,2-dihydro-2-methyl-1-oxo-4-isoquinolinyl)carbonyl)-
| 148581-48-0 |
|
Pyrrolidine,1-((10,11-dihydro-11-(4-methyl-1-piperazinyl)dibenzo(b,f)thiepin-2-yl) sulfonyl)-, methanesulfonate,hydrate (1:2:1)
| 51723-65-0 |
|
Pyrrolidine,1-(3-(3,4-dihydro-2-naphthalenyl)-1-oxo-2,3-diphenyl-2-propenyl)-
| 58271-28-6 |
|
Pyrrolidine,1-((5,6-dihydro-6-oxo-3-phenanthridinyl)carbonyl)-
| 39180-44-4 |
|
Pyrrolidine,1-((2,3-dihydro-5-oxo-5H-thiazolo(3,2-a)pyrimidin-6-yl)carbonyl)-
| 93501-42-9 |
|
Pyrrolidine,1-(((1,2-dihydro-5,6,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1- b)furan-9-yl)oxy) acetyl)-,21-acetate
| 13929-40-3 |
|
1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-, (+-)-
| 68567-97-5 |
|
Pyrrolidine,1-(2-(p-(6,7-dihydro-2-phenyl-5H-indeno(5,6-b)furan-3-yl)phenoxy)ethyl)-, hydrochloride
| 25439-45-6 |
|
|